Course Summary
Expiration Date: 09/18/2027
Clonidine is used for a variety of conditions like hypertension, attention deficit hyperactivity disorder, and for the treatment of opioid and alcohol use disorders. There are other unapproved uses for clonidine, including the treatment of anxiety and post-traumatic stress disorder. Although clonidine has a proven antihypertensive effect, it is no longer considered a primary drug for hypertension. Withdrawal syndrome and overdose can occur with clonidine use, and there is an increasing concern about the rise in cases of pediatric accidental overdose. The prevention of clonidine withdrawal syndrome and toxicity is important for health clinicians to understand to be able to diagnose and intervene when an adverse event is suspected quickly.
Course Format
Homestudy
Course Syllabus
- Introduction
- Pharmacological Profile
- Pharmacokinetics
- Mechanism of Action and Impact on Other Systems
- Dosing and Dosing Adjustments
- Adverse Reactions
- US Boxed Warning, Contraindications, and Warnings
- Pregnancy and Lactation
- Dietary Recommendations
- Treatment of Hypertension
- Clonidine Overdose and Accidental Exposure
- Case Study: Clonidine Overdose
- Accidental Overdose in a Toddler
- Adult with Clonidine Overdose
- Summary
Author
Richard Daniels, PharmD, BCPS
Richard “Cole” Daniels earned his Doctor of Pharmacy(PharmD) from the Skaggs School of Pharmacy at the University of Montana in 2018. Throughout pharmacy school he completed a 3-year internship at Community Medical Center in Missoula, Montana in which he gained valuable experience in an acute care setting. Cole currently serves as a psychiatric clinical staff pharmacist at the Montana State Hospital. He has over 11 years of pharmacy experience having worked in several settings including retail, acute care, and inpatient psychiatric care. Cole has a diverse set of interests. However, acute care medicine, infectious disease, pain management, and asthma/COPD are a primary focus of his at the Montana State Hospital. He obtained board certification as a certified pharmacotherapy specialist in the Spring of 2022.